Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A proposed stem cell research policy.

Louis M Guenin1

  • 1Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA. guenin@hms.harvard.edu

Stem Cells (Dayton, Ohio)
|August 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wishful thinking will not obviate embryo use.

Stem cell reviews·2006
Same author

On classifying the developing organism.

Connecticut law review·2005
Same author

Stem cells, cloning, and regulation.

Mayo Clinic proceedings·2005
Same author

Stem cells: shibboleths of development.

Stem cells and development·2005
Same author

A failed noncomplicity scheme.

Stem cells and development·2004
Same author

The morality of unenabled embryo use--arguments that work and arguments that don't.

Mayo Clinic proceedings·2004
Same journal

Brent A. Reynolds, pioneer of adult neural stem cell biology.

Stem cells (Dayton, Ohio)·2026
Same journal

CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.

Stem cells (Dayton, Ohio)·2026
Same journal

Transforming Growth Factor beta-2 (TGFβ2) Drives Trabecular Meshwork Progenitor Cell Differentiation Through SMAD2/3 Signalling.

Stem cells (Dayton, Ohio)·2026
Same journal

Circular RNA circEGFR overexpression attenuates chemosensitivity and enhances cancer stemness via targeting IGF2BP2/SOX2 in breast cancer cells.

Stem cells (Dayton, Ohio)·2026
Same journal

Regeneration of the mammalian brain: a relic of evolution?

Stem cells (Dayton, Ohio)·2026
Same journal

Mitochondrial transfer technologies with molecular insights into clinical applications.

Stem cells (Dayton, Ohio)·2026
See all related articles

Federal regulations on human embryonic stem cell (hESC) research present legal and ethical challenges. This analysis proposes a policy for using donated embryos to advance research while addressing moral concerns.

Area of Science:

  • Bioethics
  • Biotechnology Law
  • Stem Cell Research Policy

Background:

  • Scientist and patient aspirations for human embryonic stem cell (hESC) research in the U.S. necessitate a focus on legal and regulatory frameworks.
  • Existing federal laws and regulations governing hESC research are complex and present significant challenges.

Purpose of the Study:

  • To analyze the legal and regulatory landscape of hESC research in the U.S.
  • To evaluate the effectiveness of current and proposed policies in addressing ethical concerns, particularly regarding embryo sacrifice.
  • To propose a new public policy for the ethical advancement of hESC research.

Main Methods:

  • Analysis of federal laws and regulations pertaining to hESC research.
  • Examination of the ethical implications of embryo use in hESC research.

Related Experiment Videos

  • Development of a proposed policy for the use of donated embryos in research.

    • Main Results:

    • Current and proposed federal policies fail to achieve their objective of avoiding complicity in embryo sacrifice.
    • The Food and Drug Administration has already effectively restricted procreative cloning.
    • It is difficult to deny complicity in embryo sacrifice when conducting or funding hESC research.

    Conclusions:

    • A new rule for public policy is proposed, allowing the use of donated embryos that are barred from the womb.
    • This policy aims to optimize research while providing a moral justification for embryo use.
    • The proposed rule is adaptable for implementation by any government funding hESC research.